Article
An In Silico Analysis of Genetic Variants and Structural Modeling of the Human Frataxin Protein in Friedreich's Ataxia.
International journal of molecular sciences - 26 May 2024
Da Conceição Loiane Mendonça Abrantes, Cabral Lucio Mendes, Pereira Gabriel Rodrigues Coutinho, De Mesquita Joelma Freire
Abstract excerpt
Friedreich's Ataxia (FRDA) stands out as the most prevalent form of hereditary ataxias, marked by progressive movement ataxia, loss of vibratory sensitivity, and skeletal deformities, severely affecting daily functioning. To date, the only medication available for treating FRDA is Omaveloxolone (Skyclarys®), recently approved by the FDA. Missense mutations within the human frataxin (FXN) gene, responsible for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
